Company Information

    QED Therapeutics was founded on January 2018. The company is based in Palo Alto, CA, USA . The number of employees in QED Therapeutics is less than 50. Qed therapeutics is a biotechnology company focused on precision medicine for fgfr-driven disorders.

    Here is how QED Therapeutics describes itself: "Learn how QED Therapeutics is advancing the fight against cholangiocarcinoma and other FGFR-driven diseases through research and innovation."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          QED Therapeutics has received 1 rounds of venture funding. The total funding amount is around $65M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        QED Therapeutics - Blog


                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *